EMA — authorised 27 November 1995
- Marketing authorisation holder: Sanofi Mature IP
- Status: approved
🇪🇺 Taxotere in European Union
EMA authorised Taxotere on 27 November 1995
Marketing authorisation
Taxotere in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Taxotere approved in European Union?
Yes. EMA authorised it on 27 November 1995.
Who is the marketing authorisation holder for Taxotere in European Union?
Sanofi Mature IP holds the EU marketing authorisation.